2023 Form 5500 filing — Aileron Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240801160530NAL0039147680001) for Aileron Therapeutics, Inc. 401(K) Plan, reported by Aileron Therapeutics, Inc. under EIN 13-4196017 and plan number 001. It reports 29 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$3MReported net assets$2,972,330
Participants29
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240801160530NAL0039147680001
Plan sponsor
Aileron Therapeutics, Inc.
EIN
13-4196017
Plan number
001
Location
Waltham, MA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$3M total assets
Net assets$3MLiabilities$0
Money in vs. money out
Total income / additions$668.5K
Total expenses$498.7K
Benefits paid / distributions$498.1K
Contributions
Employer$151.8K
Participant$61.5K
Full reported line items
Total assets (EOY)
$2,972,330
Total liabilities (EOY)
$0
Net assets (EOY)
$2,972,330
Employer contributions
$151,753
Participant contributions
$61,525
Total income / additions
$668,505
Benefits paid
$498,053
Administrative expenses
$655
Total expenses
$498,708
Net increase / (decrease)
$169,797

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240801160530NAL0039147680001 cover?
It is the 2023 Form 5500 filing for Aileron Therapeutics, Inc. 401(K) Plan, reported by Aileron Therapeutics, Inc. (EIN 13-4196017).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages